Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Crowther

Showing results (161-170 of 282) with videos related to

Pageof 29
Sort By:
Cancer Research|August 1, 1994
Relationships between the formation of O6-methyldeoxyguanosine by 1-p-carboxyl-3,3-dimethylphenyltriazene in DNA and O6-alkylguanine-DNA alkyltransferase in human peripheral leukocytesS M Lee, P J O'Connor, N Thatcher, et al.
British Journal of Cancer|February 14, 1998
Bryostatin 1-tamoxifen combinations show synergistic effects on the inhibition of growth of P388 cells in vitroA T McGown, G Jayson, G R Pettit, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 1994
Immunomodulation in patients receiving intravenous Bryostatin 1 in a phase I clinical study: comparison with effects of Bryostatin 1 on lymphocyte function in vitroC Scheid, J Prendiville, G Jayson, et al.
Pediatrics|April 1, 1971
Development of children who had received intra-uterine transfusionsR H Phibbs, D Harvin, G Jones, et al.
Biochemical Pharmacology|June 1, 1989
The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivoM J Lind, A T McGown, J A Hadfield, et al.
British Journal of Cancer|January 1, 1989
Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity studyW P Steward, J H Scarffe, R Austin, et al.
British Journal of Diseases of the Chest|January 1, 1984
Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancerN Thatcher, D Honeybourne, J Wagstaff, et al.
British Journal of Cancer|January 1, 1997
Prognostic factors for disease progression in advanced Hodgkin's disease: an analysis of patients aged under 60 years showing no progression in the first 6 months after starting primary chemotherapyS M Lee, J A Radford, W D Ryder, et al.
British Medical Journal|December 16, 1978
Computed tomography of abdomen in staging and clinical management of lymphomaJ J Best, G Blackledge, W S Forbes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's diseaseJ A Radford, R A Cowan, M Flanagan, et al.
Pageof 29

Showing results (161-170 of 282) with videos related to

Sort By:
Pageof 29
Cancer Research|August 1, 1994
Relationships between the formation of O6-methyldeoxyguanosine by 1-p-carboxyl-3,3-dimethylphenyltriazene in DNA and O6-alkylguanine-DNA alkyltransferase in human peripheral leukocytesS M Lee, P J O'Connor, N Thatcher, et al.
British Journal of Cancer|February 14, 1998
Bryostatin 1-tamoxifen combinations show synergistic effects on the inhibition of growth of P388 cells in vitroA T McGown, G Jayson, G R Pettit, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 1994
Immunomodulation in patients receiving intravenous Bryostatin 1 in a phase I clinical study: comparison with effects of Bryostatin 1 on lymphocyte function in vitroC Scheid, J Prendiville, G Jayson, et al.
Pediatrics|April 1, 1971
Development of children who had received intra-uterine transfusionsR H Phibbs, D Harvin, G Jones, et al.
Biochemical Pharmacology|June 1, 1989
The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivoM J Lind, A T McGown, J A Hadfield, et al.
British Journal of Cancer|January 1, 1989
Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity studyW P Steward, J H Scarffe, R Austin, et al.
British Journal of Diseases of the Chest|January 1, 1984
Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancerN Thatcher, D Honeybourne, J Wagstaff, et al.
British Journal of Cancer|January 1, 1997
Prognostic factors for disease progression in advanced Hodgkin's disease: an analysis of patients aged under 60 years showing no progression in the first 6 months after starting primary chemotherapyS M Lee, J A Radford, W D Ryder, et al.
British Medical Journal|December 16, 1978
Computed tomography of abdomen in staging and clinical management of lymphomaJ J Best, G Blackledge, W S Forbes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
The significance of residual mediastinal abnormality on the chest radiograph following treatment for Hodgkin's diseaseJ A Radford, R A Cowan, M Flanagan, et al.
Pageof 29